Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action

@article{Scorza1999EffectsO5,
  title={Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action},
  author={Cecilia Dagert de Scorza and Rodolfo Silveira and DavidE. Nichols and Miguel Reyes-Parada},
  journal={Neuropharmacology},
  year={1999},
  volume={38},
  pages={1055-1061}
}

Figures from this paper

p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro

TLDR
Studies in synaptosomes could bring to light differences between neurotoxic and non-neurotoxic 5-HT releasing agents which cannot be appreciated in other experimental models and might be useful to identify the mechanisms responsible for the neurotoxic effects of amphetamine derivatives.

Multi-modal antidepressant-like action of 6- and 7-chloro-2-aminodihydroquinazolines in the mouse tail suspension test

TLDR
A simple shift of a substituent in aCommon quinazoline scaffold from one position to another resulted in a common action in the TST but via a somewhat different mechanism, which might represent the first members of a new class of potential antidepressants with a unique multi-modal mechanism of action.

Therapeutic and adverse actions of serotonin transporter substrates.

4‐Methylthioamphetamine Increases Dopamine in the Rat Striatum and has Rewarding Effects In Vivo

TLDR
Results show that MTA is able to increase extracellular striatal DA levels and that its administration has rewarding properties and these effects were observed at concentrations or doses that can be relevant to its use in human beings.

p‐Methylthioamphetamine and 1‐(m‐chlorophenyl)piperazine, two non‐neurotoxic 5‐HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5‐HT nerve endings in vitro

TLDR
Studies in synaptosomes could bring to light differences between neurotoxic and non‐neurotoxic 5‐HT releasing agents which cannot be appreciated in other experimental models and might be useful to identify the mechanisms responsible for the neurotoxicity induced by amphetamine derivatives.

Endogenous 5‐HT, released by MDMA through serotonin transporter‐ and secretory vesicle‐dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5‐HT1B receptors located on CA1 pyramidal neurons

TLDR
It is found that application of 5‐HT releasers, 3,4‐methylenedioxy‐methamphetamine (MDMA) or p‐methylthioamphetamine, at concentrations ranging from 2 to 50 µm, reduced the excitatory synaptic transmission between CA1 pyramidal neurons without altering their basal electrical properties.

Pharmacological Characterization of 4-Methylthioamphetamine Derivatives

TLDR
The results show that the pharmacological and safety profiles of MTA are modulated by changing the methyl-thio group or the methyl group of the aminoethyl chain.

References

SHOWING 1-10 OF 67 REFERENCES

Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.

The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain

Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo.

TLDR
Results show that removal of Trp from the balanced amino acid mixture decreases spontaneous and d-fenfluramine-induced release of 5-HT in the hippocampus, which supports the hypothesis that the mood-lowering effect observed in man after ingestion of a Trp-free amino acids mixture is associated with diminished 5- HT release in the brain.
...